https://pittplusme.org/study/1017
COMET Study
STUDY BASICS
Are you a woman age 40 or up who has been newly diagnosed (past 3 months) with non-invasive ductal carcinoma in situ (DCIS)? If so, you may be eligible for a study to help researchers evaluate the risks and benefits of usual treatment approach for DCIS vs. close monitoring approach. Study participation will last at least 5 years.
IRB: STUDY19030152
- HCC 16-207, COMPARING AN OPERATION TO MONITORING, WITH OR WITHOUT ENDOCRINE THERAPY (COMET) FOR LOW RISK DCIS: A PHASE III PROSPECTIVE RANDOMIZED TRIAL
MEET THE RESEARCHER
Priscilla McAuliffe
Priscilla McAuliffe, MD, PhD, is a surgical oncologist at UPMC CancerCenter and an assistant professor of surgery at the University of Pittsburgh School of Medicine. After earning her bachelors of science and medical degree with honors in research from Cornell University, Dr. McAuliffe completed a general surgery residency at the University of Florida in Gainesville, Fla., where she also received a PhD in molecular genetics. She underwent fellowship training in surgical oncology at the University of Texas MD Anderson Cancer Center in Houston. Dr. McAuliffe’s research interests include pre-invasive breast conditions, chemoresistance, and targeted therapeutic strategies for breast cancer.